Type 2 Diabetes Trial, Recruiting NCT06570057 Sponsor: Baqai Institute of Diabetology and Endocrinology Condition: Type 2 Diabetes
Back to Type 2 Diabetes

Type 2 Diabetes Trial, Recruiting

NCT06570057
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 20 years or older.
  • People living in the specific areas (clusters) of Karachi, Pakistan selected for this study.
  • People who are willing to take part and agree to give their consent to join.
  • People with normal blood sugar levels, slightly raised blood sugar levels, or diabetes are all welcome to take part.
  • People who are able to attend the scheduled meetings and activities as required by the study plan.

Who may not be able to join:

  • People under the age of 20 years.
  • People who are not willing to give their consent to participate.
  • People with serious health conditions that may prevent them from actively taking part in the study.
  • People who are unlikely to follow the study's required procedures and protocols.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Abdul Basit, Director, Baqai Institute of Diabetes and Endocrinology

Phone: 922136688897

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Baqai Institute of Diabetology and Endocrinology
Registry
ClinicalTrials.gov
Start date
24 June 2024
Est. completion
1 November 2026

Where this trial is recruiting

🇵🇰 Pakistan

Primary endpoints

Prevalence of Type II Diabetes Mellitus; Two-year cumulative incidence of Type II Diabetes Mellitus

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov